Identifying peripheral arterial diseases or flow limitations of the lower limb: Important aspects for cardiovascular screening for referral in physiotherapy.


Journal

Musculoskeletal science & practice
ISSN: 2468-7812
Titre abrégé: Musculoskelet Sci Pract
Pays: Netherlands
ID NLM: 101692753

Informations de publication

Date de publication:
10 2022
Historique:
received: 02 02 2022
revised: 08 06 2022
accepted: 16 06 2022
pubmed: 28 6 2022
medline: 9 9 2022
entrez: 27 6 2022
Statut: ppublish

Résumé

Many conditions could potentially cause pain in the lower limbs. One of these is peripheral arterial disease (PAD). PAD is often a real challenge to be recognized for clinicians due to symptoms that commonly mimic musculoskeletal conditions. PAD is defined as a total or partial blockage of the vessels that supply blood from the heart to the periphery. Its prevalence is around 7 percent in subjects between 55 and 59, reaching almost 25% in individuals between 95 and 99 years old. The most dominant symptom of PAD is lower limb pain. Also, PAD can produce other symptoms such as discoloration, altered skin temperature, and, when arterial blood flow is insufficient to meet the metabolic demands of resting muscle or tissue, focal areas of ischemia. In our view, physical therapists should be capable of triaging for PAD in a direct access setting. Therefore, in this Professional Issue, we present the main characteristics of PAD and the physiotherapy role in its management. A supplementary step-by-step guide will provide further resources for testing PAD.

Identifiants

pubmed: 35759957
pii: S2468-7812(22)00111-4
doi: 10.1016/j.msksp.2022.102611
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102611

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Daniel Feller (D)

Centre of Higher Education for Health Sciences, Trento, Italy. Electronic address: danielfeller.ft@gmail.com.

Andrea Giudice (A)

Department of Physical Therapy, Poliambulatorio Physio Power, Brescia, Italy. Electronic address: a.giudice@physiopower.it.

Agostino Faletra (A)

Queen Elizabeth Hospital, Clinical Support & Screening Service, Gateshead, United Kingdom. Electronic address: agostino.faletra@nhs.net.

Mattia Salomon (M)

Department of Clinical Science and Translational Medicine, University of Roma "Tor Vergata", Roma, Italy; CST Centro Sanitario Trento s.r.l., 30121, Trento, Italy. Electronic address: salomon.mattia@gmail.com.

Erasmo Galeno (E)

Polimedico Specialistico STEMA Fisiolab, Latina, Italy; Dip. Scienze mediche, chirurgiche e neuroscienze Università degli studi di Siena, Italy; Department of clinical science and translation medicine, University of Rome Tor Vergata, Roma, Italy. Electronic address: eragal@me.com.

Giacomo Rossettini (G)

School of Physiotherapy, University of Verona, Verona, Italy. Electronic address: giacomo.rossettini@gmail.com.

Fabrizio Brindisino (F)

Department of clinical science and translation medicine, University of Rome Tor Vergata, Roma, Italy; Department of Medicine and Health Science "Vincenzo Tiberio", University of Molise c/o Cardarelli Hospital, Campobasso, Italy. Electronic address: fabrindi@gmail.com.

Filippo Maselli (F)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Campus of Savona, University of Genoa, Savona, Italy; Sovrintendenza Sanitaria Regionale Puglia INAIL, Bari, Italy. Electronic address: masellifilippo76@gmail.com.

Nathan Hutting (N)

Department of Occupation and Health, School of Organisation and Development, HAN University of Applied Sciences, Nijmegen, the Netherlands. Electronic address: Nathan.Hutting@han.nl.

Firas Mourad (F)

Department of Physiotherapy, LUNEX International University of Health, Exercise and Sports, 4671, Differdange, Luxembourg; Luxembourg Health & Sport Sciences Research Institute A.s.b.l., 50, Avenue du Parc des Sports, 4671, Differdange, Luxembourg. Electronic address: firas.mourad@me.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH